A leading supplier of medicinal cannabis increased its Australian patient numbers by 27 per cent over a three-week period in April, representing 10 new patients every business day.
In an interview with Business News Australia earlier this month, Althea Group (ASX: AGH) managing director and founder Josh Fegan said patient numbers were "starting to spike", supported by an outreach program with doctors to persuade them of medicinal cannabis' benefits while providing technology to track results.
Today the company announced it had achieved the 650-patient milestone with 140 patients added between 4-26 April, and 145 healthcare professionals have now prescribed Althea's products.
"The rapid uptake has been driven by our Medical Science Liaison (MSL) team on the ground and Althea Concierge, the Company's proprietary platform that allows patients, doctors and pharmacies to manage their medicinal cannabis needs in Australia," says Althea COO Patty Holmes.
Read more at businessnewsaus.com.au
